NCT07297979 2026-04-16
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Amgen
Phase 1 Recruiting
Amgen
Eli Lilly and Company
Merck Sharp & Dohme LLC
Iovance Biotherapeutics, Inc.
Hoffmann-La Roche
Shanghai Pharmaceuticals Holding Co., Ltd